{"entity":{"type":"insider","cik":"0002068530","url":"/insider/0002068530","json_url":"/insider/0002068530.json","name":"Coastlands Capital LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2026-06-22","last":"2026-07-16","span_basis":"filed_date"},"name_variants":[{"name":"Coastlands Capital LP","source":"filing","n_filings":4,"first_seen":"2026-06-22","last_seen":"2026-07-16"}],"transactions":[{"id":6015105,"accession":"0001104659-26-084300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-084300","line_url":"/filing/0001104659-26-084300#line-2","is_derivative":false,"issuer_cik":"0001513525","issuer_name":"ADIAL PHARMACEUTICALS, INC.","issuer_ticker":"ADIL","issuer_name_source":null,"issuer_url":"/issuer/0001513525","owner_cik":"0002068530","owner_name":"Coastlands Capital LP","owner_display_name":"Coastlands Capital LP","owner_url":"/insider/0002068530","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1233.0,"shares_display":"1,233","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":3390.75,"total_display":"3,390.75","total_whole":"3,391","shares_owned_after":388308.0,"shares_owned_after_display":"388,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-16","scope":"insider"},{"id":6015101,"accession":"0001104659-26-084300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-084300","line_url":"/filing/0001104659-26-084300#line-1","is_derivative":false,"issuer_cik":"0001513525","issuer_name":"ADIAL PHARMACEUTICALS, INC.","issuer_ticker":"ADIL","issuer_name_source":null,"issuer_url":"/issuer/0001513525","owner_cik":"0002068530","owner_name":"Coastlands Capital LP","owner_display_name":"Coastlands Capital LP","owner_url":"/insider/0002068530","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.65,"price_display":"2.65","price_state":"stated","total_value":5300.0,"total_display":"5,300.00","total_whole":"5,300","shares_owned_after":387075.0,"shares_owned_after_display":"387,075","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-14","filed_date":"2026-07-16","scope":"insider"},{"id":5846108,"accession":"0001104659-26-082972","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-082972","line_url":"/filing/0001104659-26-082972#line-2","is_derivative":false,"issuer_cik":"0001513525","issuer_name":"ADIAL PHARMACEUTICALS, INC.","issuer_ticker":"ADIL","issuer_name_source":null,"issuer_url":"/issuer/0001513525","owner_cik":"0002068530","owner_name":"Coastlands Capital LP","owner_display_name":"Coastlands Capital LP","owner_url":"/insider/0002068530","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":4590.0,"total_display":"4,590.00","total_whole":"4,590","shares_owned_after":385075.0,"shares_owned_after_display":"385,075","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-10","filed_date":"2026-07-13","scope":"insider"},{"id":5846105,"accession":"0001104659-26-082972","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-082972","line_url":"/filing/0001104659-26-082972#line-1","is_derivative":false,"issuer_cik":"0001513525","issuer_name":"ADIAL PHARMACEUTICALS, INC.","issuer_ticker":"ADIL","issuer_name_source":null,"issuer_url":"/issuer/0001513525","owner_cik":"0002068530","owner_name":"Coastlands Capital LP","owner_display_name":"Coastlands Capital LP","owner_url":"/insider/0002068530","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10053.0,"shares_display":"10,053","price_per_share":2.79,"price_display":"2.79","price_state":"stated","total_value":28047.87,"total_display":"28,047.87","total_whole":"28,048","shares_owned_after":383375.0,"shares_owned_after_display":"383,375","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-13","scope":"insider"},{"id":6056966,"accession":"0001104659-26-079686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-079686","line_url":"/filing/0001104659-26-079686#line-1","is_derivative":false,"issuer_cik":"0001513525","issuer_name":"ADIAL PHARMACEUTICALS, INC.","issuer_ticker":"ADIL","issuer_name_source":null,"issuer_url":"/issuer/0001513525","owner_cik":"0002068530","owner_name":"Coastlands Capital LP","owner_display_name":"Coastlands Capital LP","owner_url":"/insider/0002068530","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":65000.0,"total_display":"65,000.00","total_whole":"65,000","shares_owned_after":373322.0,"shares_owned_after_display":"373,322","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider"},{"id":5846063,"accession":"0001104659-26-076184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-076184","line_url":"/filing/0001104659-26-076184#line-1","is_derivative":false,"issuer_cik":"0001841330","issuer_name":"Pasithea Therapeutics Corp.","issuer_ticker":"KTTA","issuer_name_source":null,"issuer_url":"/issuer/0001841330","owner_cik":"0002068530","owner_name":"Coastlands Capital LP","owner_display_name":"Coastlands Capital LP","owner_url":"/insider/0002068530","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.53,"price_display":"0.53","price_state":"stated","total_value":53000.0,"total_display":"53,000.00","total_whole":"53,000","shares_owned_after":3835035.0,"shares_owned_after_display":"3,835,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001513525","name":"ADIAL PHARMACEUTICALS, INC.","url":"/issuer/0001513525","role":"Ten percent owner","n_filings":3,"first_seen":"2026-07-01","last_seen":"2026-07-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001841330","name":"Pasithea Therapeutics Corp.","url":"/issuer/0001841330","role":"Ten percent owner","n_filings":1,"first_seen":"2026-06-22","last_seen":"2026-06-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002068530","retrieved_at":"2026-08-23T17:09:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}